Ndonovo Therapeutics Inc (ENDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 19 | 5 | 548 | 59 |
| Receivables | 3 | 23 | 11 | 8 | 10 |
| Inventories | N/A | N/A | 23 | N/A | N/A |
| TOTAL | $18 | $63 | $39 | $586 | $69 |
| Non-Current Assets | |||||
| PPE Net | 4 | 6 | 7 | 7 | 6 |
| Intangibles | 3,045 | 3,206 | 3,368 | 3,530 | 3,691 |
| TOTAL | $3,049 | $3,212 | $3,375 | $3,537 | $3,697 |
| Total Assets | $3,067 | $3,275 | $3,414 | $4,123 | $3,766 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 577 | 600 | 346 | 281 | 199 |
| Accrued Expenses | 1,487 | 1,317 | 1,128 | 928 | 978 |
| Other current liabilities | 5,810 | 14,845 | 11,218 | 12,224 | 7,783 |
| TOTAL | $14,054 | $23,624 | $19,825 | $20,214 | $15,236 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 155 | 155 | 155 | 155 | 155 |
| TOTAL | $155 | $155 | $155 | $155 | $155 |
| Total Liabilities | $14,209 | $23,779 | $19,980 | $20,369 | $15,391 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,503 | 8,814 | 931 | 761 | 558 |
| Common Shares | 1 | 0 | 83 | 73 | 52 |
| Retained earnings | -48,596 | -52,935 | -47,270 | -45,864 | -38,027 |
| Other shareholders' equity | -2 | -2 | -2 | -2 | -2 |
| TOTAL | $-11,142 | $-20,504 | $-16,566 | $-16,247 | $-11,625 |
| Total Liabilities And Equity | $3,067 | $3,275 | $3,414 | $4,123 | $3,766 |